Medtronic begins shipping Micro Jewel AICD; Sprint lead pending at FDA.
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC ANTICIPATES SPRINT DEFIBRILLATOR LEAD FDA APPROVAL later this year, the company says. A marketing application for the 7.8 French lead (model 6932) was submitted to the agency in March, and U.S. clinicals are ongoing. The Sprint lead will enable surgeons to program implantable defibrillators to deliver less energy if the patient does not require defibrillation at full energy levels, Medtronic says.